CPT vs JPM Stock Comparison
JPM currently leads CPT in this stock comparison, with AIQ scores of 52 vs 44. The clearest difference is quality, while CPT has the stronger risk resilience profile.
What is the main difference between CPT and JPM?
JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Camden Property Trust vs JPMorgan Chase & Co.
JPM leads
JPM leads by 8 AIQ points, primarily on Quality and Value.
Stable: 4 of 6 evidence groups support JPM, and its signal state is cleanly positive.
Camden Property Trust
JPMorgan Chase & Co.
The Algovestiq AIQ Score currently favors JPM over CPT, 52 versus 44 as of Oct 21, 2026. JPM's advantage is driven primarily by stronger quality and value, while CPT holds the stronger risk resilience profile. JPM also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor JPM today, and the comparison is rated Stable on stability. JPM lead: Stable — the AIQ differential has held near 8 points over 30 sessions.
Compare Camden Property Trust and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare CPT and JPM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality29 vs 46JPM +17
- Value36 vs 44JPM +8
- Risk Resilience72 vs 68CPT +4
- Momentum55 vs 58Even
4 of 6 evidence groups favor JPM. JPM’s edge is concentrated in quality and value; CPT keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +14
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
Largest factor move: Momentum +8
No signal started or stopped since the prior session; its 2 active signals are unchanged.
JPM's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — CPT and JPM both carry a full feed there.
The central trade-off
JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by quality and value.
CPT (Camden Property Trust): the counter-case, on risk resilience.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
JPMJPM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
JPMJPM on combined revenue and EPS growth.
Value
JPMJPM on the peer-relative Value factor, by 8 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
CPTCPT on Risk Resilience, by 4 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CPT | JPM | Note |
|---|---|---|---|
| Implied upside to target | +12.2% | +11.3% | Level |
| Target dispersion | +25.1% | +32.2% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 13 | 11 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
Dividend growth
| Dividend metric | CPT | JPM |
|---|---|---|
| 5Y dividend CAGR | 4.81% | 9.04% |
| 2020 regular DPS | $3.320 | $3.600 |
| 2025 regular DPS | $4.200 | $5.550 |
| Years increased | 4 | 5 |
| No cut in window | Yes | Yes |
| Cohort rank | #18 | #120 |
JPM grew its split-adjusted regular dividend faster over 2020–2025 — 9.04% a year against CPT's 4.81%. Neither company reduced its regular dividend in any year of the window. They are ranked in different cohorts — REITs and US dividend-paying corporations — so their ranks are not comparable with each other.
Yield and payout ratio shown elsewhere on this page are current values, not part of the study window.
Split-adjusted regular dividends per share, 2020–2025, excluding special dividends. Research as of Sep 19, 2026.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | JPM | 44 vs 52 |
| Fundamentals | JPMon balance | revenue growth 1.2% vs -7.6%; EPS growth -55% vs -27.6%; TTM ROE 7.8% vs 17.9%; gross margin 22.3% vs 63.2%; operating margin 17.8% vs 28.2% — JPM takes 4 of 5 decided legs, not all of them |
| Valuation | JPM | Value 36 vs 44 |
| Technicals | JPM | Price vs 50-day -2.1% vs -3.4%; vs 200-day -6.1% vs 4% |
| Risk Resilience | CPT | Risk Resilience 72 vs 68 |
| Analyst expectations | Even | Target upside 12.2% vs 11.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CPT and JPM and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is moderate at 8 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20JPM lead: Stable — the AIQ differential has held near 8 points over 30 sessions.
- Today
- JPM +8
- 44 vs 52
- 7 sessions ago
- JPM +6
- 41 vs 47
- 30 sessions ago
- JPM +7
- 36 vs 43
- 90 sessions ago
- JPM +11
- 42 vs 53
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 4 bearish / 1 neutral, conflicted
Only CPT
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Death Cross Active — bearish, trend, long horizon (3.87%)
- BB Upper Band Breach — bearish, volatility, short horizon
- 52-Week Low Proximity — bearish, risk, long horizon (2.0%)
- Downtrend Structure Active — bearish, trend, long horizon
2 bullish / 0 bearish
Only JPM
- Golden Cross Active — bullish, trend, long horizon (7.65%)
Both carry 1 more signal that do not separate them: MACD Bullish Crossover.
CPT is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +0.42%, AIQ +3 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.02%, AIQ +3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CPT closes the Quality gap — currently 17 points behind, the largest single contributor to JPM's edge.
- 2CPT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3JPM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
JPM leads on balance| Metric | CPT | JPM |
|---|---|---|
| Revenue growth (YoY) | 1.2% | -7.6% |
| EPS growth (YoY) | -55% | -27.6% |
| Gross margin | 22.3% | 63.2% |
| Operating margin | 17.8% | 28.2% |
| Return on equity (TTM) | 7.8% | 17.9% |
| Debt to equity | 1.28 | 3.32 |
Performance
JPM leads 4 of 6 windows| Metric | CPT | JPM |
|---|---|---|
| 1 week (5 sessions) | 1.8% | 1.2% |
| 1 month (20 sessions) | 0.5% | -1.4% |
| 3 months (63 sessions) | -10.9% | -3.7% |
| 6 months (126 sessions) | -2.6% | 7.1% |
| Year to date | -9.4% | 4% |
| 1 year (252 sessions) | -2% | 12.3% |
Technicals
JPM has the stronger structure| Metric | CPT | JPM |
|---|---|---|
| RSI (14) | 63.5 | 57.4 |
| ADX (14) | 32.9 | 20.5 |
| Price vs 50-day | -2.1% | -3.4% |
| Price vs 200-day | -6.1% | 4% |
| Volatility (1M, annualized) | 16.6% | 14.8% |
Risk
CPT is the more resilient| Metric | CPT | JPM |
|---|---|---|
| Beta | 0.08 | 0.75 |
| Sharpe ratio | -0.23 | 0.47 |
| Sortino ratio | -0.36 | 0.66 |
| Max drawdown | -18.5% | -15.5% |
| Current drawdown | -15.2% | -8.2% |
| Annualized volatility | 19.8% | 22.2% |
| Value at risk (95%) | -2% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CPT or JPM?
On the Algovestiq AIQ Score, JPM is the stronger of the two as of Oct 21, 2026, scoring 52 against CPT's 44. The edge comes from quality and value. CPT is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CPT or JPM the better buy right now?
JPM carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor JPM over CPT?
The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Quality by 17 points; JPM leads Value by 8 points; CPT leads Risk Resilience by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CPT or JPM?
Analyst price targets imply +12.2% upside for CPT and +11.3% for JPM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CPT or JPM?
JPM is the better-valued of the two on the peer-relative Value factor. JPM on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CPT or JPM?
JPM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CPT or JPM?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CPT or JPM?
CPT is the more resilient of the two, so the other name carries the higher downside risk. CPT on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CPT more profitable than JPM?
JPM leads on the comparable margin measures — gross margin 22.3% vs 63.2%; operating margin 17.8% vs 28.2%; ttm roe 7.8% vs 17.9%.
Is JPM's lead over CPT getting stronger or weaker?
JPM lead: Stable — the AIQ differential has held near 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.
What would change the CPT vs JPM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CPT closes the Quality gap — currently 17 points behind, the largest single contributor to JPM's edge; CPT's Death Cross Active resolves — a bearish trend rule currently active against it; JPM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CPT and JPM?
CPT: 1 bullish / 4 bearish / 1 neutral, conflicted. JPM: 2 bullish / 0 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CPT is Death Cross Active (bearish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).
Compare CPT and JPM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.